News by Tag: Biosimilar Players

Cri-report - Risk - Reward of Developing a Herceptin Biosimilar - A Thorough Assessment
October 16, 2012
Herceptin exclusivity is expiring in major geographies and many Biosimilar players (both experienced and new entrant) are looking to have a share of this potential $6billion pie. Herceptin sales are critical to Roche as it comprise about 15% of its c

PR HWY Homepage
Submit Press Release
PR Firms Directory
Pricing & Features

prHWY offers affordable press release packages with several enhanced options to maximize exposure. By offering homepage featured press releases at an affordable price, you can take advantage of allowing your news article top placement and visibility. Distribute your business news today with prHWY, the most cost effective press release submission service on the internet!